Skip to content

Sam's News — health — 2026-08-13

Health

7 California Insulin Brand Distributes 120,000 Packs at $55 Price Point

California's low-cost insulin glargine brand has distributed over 120,000 five-pen packs at $55 each, approximately seven months after launch.

  • 120,000 five-pen packs distributed
  • $55 per pack price point
  • Seven months post-launch

Sources: STAT News AI Web Searched

5.5 DRC and WHO Advance Clinical Trial Launch for Ebola Vaccines

The Democratic Republic of the Congo and WHO are negotiating to expedite the start of a Phase 3 multi-armed clinical trial for Ebola vaccines.

Sources: STAT News RSS

5 Eli Lilly Targets Black Market for Retatrutide Weight Loss Drug

Eli Lilly is addressing the illicit market for retatrutide, a weight loss medication, as unauthorized supply continues to circumvent official distribution channels.

Sources: STAT News RSS

Medicare is implementing new incentive structures for AI-enabled medical devices alongside scrutiny of health tech firm Commure.

Sources: STAT News RSS

5 Vaping and Cannabis Use Hit Record Highs Among Young Adults in 2025

A new survey reports all-time high usage rates of vapes and cannabis among young adults in 2025.

Sources: STAT News RSS

Oncology

6 New fertility preservation technologies expand post-cancer parenthood options for young patients

Cancer doctors and reproductive specialists are collaborating to provide young cancer patients with new fertility preservation and assisted reproduction options.

Sources: STAT News RSS

Health Policy

5.5 Health secretary Kennedy visits California to outline new addiction treatment strategy

The health secretary travels to California to present the government's revised approach to addiction treatment.

Sources: STAT News RSS

5.5 Medicare incentives for AI-based medical devices could drive overuse in hospitals

Researchers warn that Medicare payment incentives for newly-authorized AI devices may encourage hospitals to overutilize these technologies.

Sources: STAT News RSS

5.5 California's generic insulin program slow to reach patients despite governor push

Gov. Newsom's CalRx generic insulin initiative is progressing slowly in reaching patients despite the state's emphasis on affordable healthcare.

Sources: STAT News RSS

Mental Health

5.5 Study reveals patient perspectives on minimally invasive brain implants for depression

New research surveyed patients with treatment-resistant depression about their concerns and preferences regarding minimally invasive brain implant technology.

Sources: STAT News RSS